Semper Augustus Investments Group GEHC trades
Christopher Bloomstran
Christopher Bloomstran GE HealthCare Technologies Inc stake
total: 94
Trades details
- Total transactions:
- 2
- New positions:
- 1
- Reduced:
- 1
- Held since:
- 2023 Q1
- Held for:
- 14 quarters
- Latest activity:
- 2023 Q2
According to 2026 Q2 report, Christopher Bloomstran holds 4,581 GE HealthCare Technologies Inc (GEHC) shares with a market value of roughly $293.23K accounting for 0.03% of the overall portfolio. To date, the estimated cost basis is nearly $82.03 for "buy" trades and estimated average "sell" price is $81.24. Semper Augustus Investments Group first purchased GEHC in 2023 Q1, initially acquiring 5,936 shares. Since the initial investment in GE HealthCare Technologies Inc (GEHC), Semper Augustus Investments Group has made 1 more transaction.
When did Christopher Bloomstran buy GE HealthCare Technologies Inc (GEHC)?
Christopher Bloomstran first invested in GE HealthCare Technologies Inc (GEHC) in 2023 Q1 at the reported quarter-end price of $82.03 per share.
What's the cost basis of Semper Augustus Investments Group's GEHC stake?
The estimated cost basis for GE HealthCare Technologies Inc (GEHC) stake is around $82.03 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $82.03
- Weighted AVG sell price:
- $81.24
Christopher Bloomstran's historical trades in GE HealthCare Technologies Inc
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q2
|
0.09%
|
4,581
|
$81.24
|
$372,160
|
-22.83% (-1,355)
|
-0.03%
|
|
2023 Q1
|
0.12%
|
5,936
|
$82.03
|
$486,930
|
new
|
+0.12%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.